A growing body of large-scale research is fueling a provocative claim: that exercise may be as effective as established treatments — including medication and psychotherapy — for depression and anxiety. According to The Economist's reporting, several major studies have now reached this conclusion, reigniting a long-running debate in psychiatry and public health.
The findings arrive at a moment when mental health systems in many countries are under severe strain, with waiting lists for therapy stretching months and antidepressant prescriptions at record levels. If exercise truly rivals these interventions, the implications for health policy would be profound. Yet many experts remain cautious, pointing to methodological concerns that complicate the headline-grabbing results.
The promise and the problem of big meta-analyses
The case for exercise as a mental health intervention has been building for years, but recent umbrella reviews and meta-analyses — studies that aggregate findings from dozens or hundreds of smaller trials — have given it new statistical heft. These large syntheses tend to show effect sizes for exercise that are comparable to, and sometimes exceed, those of cognitive behavioral therapy or selective serotonin reuptake inhibitors (SSRIs) for mild to moderate depression.
The appeal is intuitive. Exercise is low-cost, widely accessible, and carries a range of secondary health benefits that no pill can replicate. For policymakers grappling with overstretched mental health services, the idea of prescribing running shoes instead of Prozac has obvious allure. But the reservations voiced by researchers are not trivial. Blinding — a cornerstone of rigorous clinical trials — is essentially impossible in exercise studies: participants know whether they are running on a treadmill or sitting in a waiting room. This introduces significant placebo and expectation effects that are difficult to control for. Many trials also suffer from high dropout rates, small sample sizes, and inconsistent definitions of what constitutes "exercise."
What the debate reveals about mental health research
The tension between enthusiastic meta-analytic findings and skeptical expert commentary reflects a broader challenge in mental health science. Depression and anxiety are not single diseases with uniform causes; they are heterogeneous conditions influenced by genetics, environment, trauma, and neurochemistry. A treatment that works well for one patient profile may do little for another. Meta-analyses, by design, smooth over this variation to produce aggregate conclusions — useful for policy discussions, but potentially misleading at the individual clinical level.
There is also a risk that the "exercise as treatment" narrative, if oversimplified, could be used to justify reduced investment in conventional mental health services. Telling a patient with severe, treatment-resistant depression to go for a jog is not merely unhelpful — it can be harmful, reinforcing the stigma that mental illness is a matter of willpower. Most researchers who study exercise and mental health are careful to frame physical activity as a complement to, rather than a replacement for, established treatments. The nuance, however, is easily lost in translation from journal to headline.
The underlying science is not in dispute: regular physical activity appears to have genuine antidepressant and anxiolytic effects, likely mediated through neuroplasticity, inflammation reduction, and improved sleep. What remains contested is the magnitude of those effects relative to other interventions, and whether the evidence base is robust enough to reshape clinical guidelines.
As the research matures and trial designs improve, the question is less whether exercise helps — few serious scientists doubt that it does — and more how it should be integrated into treatment frameworks without displacing the pharmacological and therapeutic tools that millions of patients depend on. The answer will require a level of precision that meta-analyses alone cannot provide.
With reporting from The Economist
Source · The Economist — Science & Technology
